Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial

Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial

Abstract Background The effectiveness and safety of moderately hypofractionated radiotherapy (HFRT) in patients undergoing breast-conserving surgery (BCS) has been demonstrated in several pivotal randomized trials. However, the feasibility of applying simultaneous integrated boost (SIB) to the tumor...

Full description

Bibliographic Details
Main Authors: Kairui Jin, Jurui Luo, Xiaoli Yu, Xiaomao Guo
Format: Article
Language:English
Published: BMC 2024-05-01
Series:Radiation Oncology
Subjects:
Hypofractionated radiotherapy
Simutaneous integrated boost
Regional node irradiation
Breast cancer
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13014-024-02449-y

Internet

https://doi.org/10.1186/s13014-024-02449-y

Similar Items